Pyrroloquinoline Quinone: A Novel Vitamin?

7
Lead Review Article October 1998: 287-293 Pyrroloquinoline Quinone: A Novel Vitamin? Amy Bishop, Ph.D., Paul M. Gallop, Ph.D., and Manli-ed L. Karnovsky, Ph.D. Pyrroloquinolinequinone (PQQ), otherwise known as methoxatin, is a water-soluble, redox-cycling orthoquinone that was initially isolated from cul- tures of methylotropic bacteria. It has been found to be a cofactor of some bacterial alcohol dehy- drogenases, and is present in many animal tissues. It may be a novel vitamin because it has been shown to be essential for normal growth and de- velopment. The redox-cycling ability of PQQ en- ables it to scavenge or generate superoxide. When fed to animals as a supplement, PQQ prevents oxidative changes that would ordinarily OCCUL It has been reported to inhibit glutamate decarboxy- lase activity and protect against N-methyl-D-aspar- tate (NMDA) receptor-mediated neurotoxicity in the brain. It appears that in the whole animal, how- ever, PQQ does not cross the blood-brain barrier. Furthermore, it increases nerve growth factor (NGF) synthesis in mouse astroglial cells, but has to be bound to glycine to penetrate and exert this effect in whole brain. It may therefore be regarded as a Yanus faced molecule, with its potential for a therapeutic role in the brain still in question. Discovery of PQQ Pyrroloquinoline quinone (PQQ) was initiallyisolated fi-om cultures of methylotropic bacteria as a crystalline acetone adduct. It was found to be a cofactor of many bacterial primary alcohol dehydrogenases.' Its structure was de- duced from x-ray diffraction data and confirmed by or- ganic synthesisZ (Figure 1). After the discovery of PQQ in bacteria, the search for PQQ in animal systems began. Dr. Bishop is at the Department of Molecular and Cellular Toxicology, Harvard School of Public Health; Dr. Gallop (now deceased) was at the Laboratory of Human Biochemistry, Children's Hospital; and Dr. Karnovsky is at the Department of BiologicalChemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 021 15, USA. Presence of Native PQQ in Animal Systems and Cellular Extracts In animal systems, PQQ was first thought to be a co- valently bound cofactor of quinoprotein enzymes,= such as lysyl oxidase?JO Lysyl oxidase catalyzes covalent cross- linking in collagen and elastin by oxidatively deaminating peptidyl lysine to peptidyl a-aminoadipic aldehyde (allysine). The latter reacts across chains." In fact, many oxidases do not have PQQ itself as a cofactor but as a substance with a redox-cycling quinoid group that func- tions like PQQ.12J3 Although free PQQ in the presence of copper and oxygen can oxidize lysine residues in collagen to aldehydes, the reaction lacks the specificity of the en- zymatic process.1° PQQ has bgen isolated from several mammalian bio- logic fluids such as plasma, synovial fluid, and bile at concentrations ranging from 50 to 500 pm~ledml.'"'~ It also is present at very high levels in milk and colostrum. Nursing rat dams supply their pups with high concentra- tions of PQQ, indicating that it has a role in neonatal de- ve10pment.l~ Chicken egg yolks and egg whites also con- tain high levels of PQQ consistent with the developing chick's need for PQQ.I5 Red cell hemolysates as well as neutrophils and monocytes contain dialyzable PQQ.16,18,19 The concentration of PQQ in the cytosol of neutrophils is 300 times that of the surrounding pla~rna.'~,'~ The native substance has been found in brain and cerebrospinal fluid COOH HOOC 0 PQQ Figure 1. PQQ is a free, water-soluble, anionic compound. It is a redox-cycling planar orthoquinone. Nutrition Reviews, Vol. 56, No. 10 287

Transcript of Pyrroloquinoline Quinone: A Novel Vitamin?

Page 1: Pyrroloquinoline Quinone: A Novel Vitamin?

Lead Review Article October 1998: 287-293

Pyrroloquinoline Quinone: A Novel Vitamin? Amy Bishop, Ph.D., Paul M. Gallop, Ph.D., and Manli-ed L. Karnovsky, Ph.D.

Pyrroloquinoline quinone (PQQ), otherwise known as methoxatin, is a water-soluble, redox-cycling orthoquinone that was initially isolated from cul- tures of methylotropic bacteria. It has been found to be a cofactor of some bacterial alcohol dehy- drogenases, and is present in many animal tissues. It may be a novel vitamin because it has been shown to be essential for normal growth and de- velopment. The redox-cycling ability of PQQ en- ables it to scavenge or generate superoxide. When fed to animals as a supplement, PQQ prevents oxidative changes that would ordinarily OCCUL It has been reported to inhibit glutamate decarboxy- lase activity and protect against N-methyl-D-aspar- tate (NMDA) receptor-mediated neurotoxicity in the brain. It appears that in the whole animal, how- ever, PQQ does not cross the blood-brain barrier. Furthermore, it increases nerve growth factor (NGF) synthesis in mouse astroglial cells, but has to be bound to glycine to penetrate and exert this effect in whole brain. It may therefore be regarded as a Yanus faced molecule, with its potential for a therapeutic role in the brain still in question.

Discovery of PQQ

Pyrroloquinoline quinone (PQQ) was initially isolated fi-om cultures of methylotropic bacteria as a crystalline acetone adduct. It was found to be a cofactor of many bacterial primary alcohol dehydrogenases.' Its structure was de- duced from x-ray diffraction data and confirmed by or- ganic synthesisZ (Figure 1). After the discovery of PQQ in bacteria, the search for PQQ in animal systems began.

Dr. Bishop is at the Department of Molecular and Cellular Toxicology, Harvard School of Public Health; Dr. Gallop (now deceased) was at the Laboratory of Human Biochemistry, Children's Hospital; and Dr. Karnovsky is at the Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 021 15, USA.

Presence of Native PQQ in Animal Systems and Cellular Extracts

In animal systems, PQQ was first thought to be a co- valently bound cofactor of quinoprotein enzymes,= such as lysyl oxidase?JO Lysyl oxidase catalyzes covalent cross- linking in collagen and elastin by oxidatively deaminating peptidyl lysine to peptidyl a-aminoadipic aldehyde (allysine). The latter reacts across chains." In fact, many oxidases do not have PQQ itself as a cofactor but as a substance with a redox-cycling quinoid group that func- tions like PQQ.12J3 Although free PQQ in the presence of copper and oxygen can oxidize lysine residues in collagen to aldehydes, the reaction lacks the specificity of the en- zymatic process.1°

PQQ has bgen isolated from several mammalian bio- logic fluids such as plasma, synovial fluid, and bile at concentrations ranging from 50 to 500 pm~ledml. '" '~ It also is present at very high levels in milk and colostrum. Nursing rat dams supply their pups with high concentra- tions of PQQ, indicating that it has a role in neonatal de- ve10pment.l~ Chicken egg yolks and egg whites also con- tain high levels of PQQ consistent with the developing chick's need for PQQ.I5 Red cell hemolysates as well as neutrophils and monocytes contain dialyzable PQQ.16,18,19 The concentration of PQQ in the cytosol of neutrophils is 300 times that of the surrounding pla~rna. '~, '~ The native substance has been found in brain and cerebrospinal fluid

COOH

HOOC

0 PQQ

Figure 1. PQQ is a free, water-soluble, anionic compound. It is a redox-cycling planar orthoquinone.

Nutrition Reviews, Vol. 56, No. 10 287

Page 2: Pyrroloquinoline Quinone: A Novel Vitamin?

Glycine (reduced) PQQ (reduced) Superoxide Formazan NH,-CH,-COOH-J [ QP(OH), I] [ 20; 1 [TH+H+

Glycine (oxidized) PQQ Oxygen Nitroblue Tetrazolium NH=CH-COOH QP(=O), 20, T+

Figure 2. The nitroblue tetrazolium assay (NBT) is the method of choice for detecting picomolar amounts of PQQ. The sample that contains PQQ is incubated with an excess of glycine, which reduces PQQ. The reduced PQQ goes on to reduce oxygen to superoxide, which reduces NBT to a formazan that is purple. The now oxidized PQQ is reduced by the excess glycine and can enter this cycle again. In this way, small amounts of PQQ can cycle and produce much forrnazan and, hence, be detected by colorimetric methods.

(CSF) of rats and humans.14 Of pathologic importance is the fact that patients with Parkinson’s disease have lower levels of PQQ in CSF and higher levels in blood serum than do healthy patients.I4J7 The CSF of aged rats has less PQQ than that of ordinary adult rats.l4

The aforementioned concentrations of PQQ were de- termined using a nitroblue tetrazolium (NBT) redox-cy- cling assay (Figure 2) as well as high-pressure liquid chromatography (HPLC).’”O It should be noted that the starting biologic sample was never lyophilized or stored for long periods of time, because native PQQ is sznsitive and easily lost. Kumazawa et a1.2’J2 demonstrated the presence of PQQ in various biologic tissues and foods with a different method. These researchers added phenyltrimethylammonium hydroxide (PTMA) to the tis- sue to derivatize native PQQ. The derivatized PQQ was then isolated from tissue lysates and analyzed by gas chro- matography and mass spectrometry. This method allows for verification of the structure of the compound isolated, and it was indeed PQQ. This study conclusively and rig- orously demonstrated the presence of PQQ in animals.2’J2 The PQQ concentrations detected, however, were much lower than those found in the study using the redox-cy- cling assay.”I7 Perhaps the isolation procedures employed by Kumazawa et al. were destructive to PQQ or the derivatization was not complete.

Thus far, the PQQ present in animal systems has been proven to be a free, noncovalently linked cofactor of ani- mal 0xidases.’”’~2~.~~ There is preliminary evidence that it is a dissociable cofactor of the reduced nicotinamide ad- enine dinucleotide OH)-ubiquinone reductase of com- plex 1 in mito~hondria.2~2~ Known mitochondrial poisons that inhibit the NADH-ubiquinone reductase of complex 1 in mitochondria (e.g., methylphenyl tetrahydropyridine W T P ] and rotenone) have been shown to bind PQQ in ~ i t r o . ~ ~ , * ~ Furthermore, aryl iodonium salts, such as diphenylene iodonium (DPI), that also have been shown to be strong complex 1 inhibitors, are specific inhibitors of PQQ redox c y ~ l i n g . 2 ~ ~ ~ These aryl iodonium compounds form adducts with PQQ that are stable and can be isolated and analy~ed.2~ A rigorous demonstration of the presence of PQQ in mitochondrial systems is still needed. Studies are required to isolate native PQQhnhibitor adducts from mitochondrial preparations and to verifi their structure

by mass spectroscopy and HPLC. There is some evidence for a role of PQQ in the flavin

reductase sytem, which is present in the heart and eryth- rocyte~?~ Preincubation of NADPH, PQQ, and flavin re- ductase in vitro resulted in a diminished formation of the damaging ferry1 myoglobin radical. In vitro, flavin reduc- tase catalyzes the reduction of PQQ by NADPH. The re- duced PQQ then goes on to reduce the ferrylmyoglobin radical to a functional ferrous myoglobin. Preincubation of hearts hung on a Langendorf apparatus with PQQ be- fore the ischemicheperfusion insult lessened significantly the extent of injury.25 The protection that PQQ provides the heart fiom repefi ion injury suggests that native PQQ is the electron donor for this r edu~ tase .~~ Further studies are required to identifj a suitable antibody to PQQ for use in its detection in this and other reductases.

It has been discovered recently that PQQ is present in neutrophils and possibly involved in the “respiratory burstYylsJ9 of these cells when stimulated. In a stimulated neutrophil, superoxide anion is ~ecreted.2~2~ Agents that were shown to bind PQQ in vitro (4,5-dimethyl-lY2-phe- nylene diamine [DIMDA] and DPI) inhibited superoxide production by neutrophils and m o n o c y t e ~ . ~ ~ J ~ * ~ ~ , ~ ~ Ad- ducts of inhibitory agents and native PQQ were isolated from neutrophils and analyzed by HPLC.18J9 Peaks that had the same elution time and absorbance characteristics of a standard PQQ adduct were thought to be the native PQQ adduct. The inhibition of neutrophil superoxide pro- duction by DPI and DIMDA and subsequent isolation of a PQQ-DPI or PQQ-DIMDA adduct is a powerful method for establishing the role of PQQ in a cell. These findings, when considered with other in vitro studies by Xu et al.,25 which show that PQQ could take reducing equivalents fiom NADPH, suggest again that PQQ may be a dissociable cofactor of the neutrophil NADPH oxido-reductase sys- tem (Figure 3 9 At the very least, the data suggest that native PQQ is somehow involved in the neutrophil oxida- tive burst, but the mechanism is still not clear.

Absorption and Distribution of Exogenous PQQ in Mammalian Systems

The ability of mammals to absorb and distribute exog- enous PQQ was examined to determine whether native

288 Nutrition Reviews, Vol. 56, No. 10

Page 3: Pyrroloquinoline Quinone: A Novel Vitamin?

NADP+

0 NADPH

DPI DIMDA

0 2

k k

Flavoprotein

0;

DPI Figure 3. PQQ is a putative component of the phagocyte oxidative burst system. One place where PQQ perhaps exerts its effects is indicated. Reduced NADPH reduces PQQ(=O) to PQQ(2H). The PQQ(2H) then might reduce the flavoproteidcytochrome b complex, which can then reduce oxygen to superoxide. When the PQQ is sequestered by diphenylene iodonium . (DPI), this chain is blocked and no superoxide is produced. Dimethylphenylene diamine (DIMJlA) also sequesters PQQ, which blocks the chain, producing no super- oxide.'* Inhibitors are italicized.

PQQ in animal tissues comes from dietary sources. PQQ was radiolabeled and given to mice orally.3O Most of it was absorbed by the gut. After 6 hours, much of the labeled PQQ was excreted in the urine, but a significant portion remained in the bloodstream, internalized by the red and white cells30 at concentrations suggesting that PQQ is brought into the cell via an active transport system rather than by passive diffu~ion. '~J~

Native PQQ as an Essential Nutrient in Animal Systems

A pivotal set of experiments performed by Smidt et al.31 and Killgore et al.32 demonstrated that PQQ is an essential nutrient in mammals and indicated that PQQ is at least partially obtained from dietary sources. Pregnant and nurs- ing mice were made PQQ deficient. Antibiotics were added to the diet to kill intestinal flora, and the mice were reared in a sterile environment to eliminate the possibility of ob- taining PQQ from ba~ te r i a .~ ' .~~ The chow and water were assayed for PQQ to make sure the diet was completely PQQ free.3'~~~ The PQQ-deficient female mice, when mated, were found to be sterile or, when successfully impreg- nated, to have litters that were cannibalized at birth.32 Clearly, the health of the adult animal is impacted nega- tively by PQQ deficiency. Eight of the 40 deprived off- spring died of aortic aneurysms or abdominal hemorrhages after 8 weeks of PQQ deprivati~n.~~ Surviving offspring of PQQ-deficient dams exhibited fiiable skin, alopecia, and a hunched p o ~ t u r e . ~ ' , ~ ~ When PQQ-deprived pregnant mice were given supplementary PQQ (800 nglg diet), their off- spring were normal in ap~earance.~'J~

The results of these studies support the importance of PQQ in normal neonatal development. In the offspring, PQQ deprivation resulted in decreased cross-linking of collagen and ela~tin.~'J* The deprived mice had only 10% to 30% the level of lysyl oxidase of normal mice.32 The data, when considered with the study of Shah et al.,'O further implicate PQQ as a free cofactor of lysyl oxidase. These physiologic effects of PQQ deficiency are reminis-

cent of osteolathyrism, a condition brought about by a diet high in the chickling pea (Lathyrus odoratus) in which the toxic agent is P-amin~propionitrile.~~ Interestingly, aminonitriles, such as P-aminopropionitrile, are antago- nists of PQQ in the NBT-formazan system.I6

Studies also have demonstrated decreased immunity in PQQ-deficient mice.30 Splenocytes from 20-week-old mice were cultured in the presence of the T-cell mitogen, concanavalin A, and the B-cell mitogen, lipopolysaccha- ride. The degree of cellular mitosis stimulated by the mito- gens was assayed by incorporation of [3H] thymidine into the cellular DNA. Mice that received < 200 ng PQQ/g diet had splenocytes with depressed mitotic ability. This de- pression was not reversible upon administration of PQQ to the PQQ-deprived mice.3O The data, when considered with the aforementioned neutrophil data, imply that PQQ is important for immunity.

The splenocyte study is particularly revealing when coupled with results of Naito et al.," who added PQQ to human fibroblasts and scored mitogenicity by rate of [3H] thymidine incorporation. As little as 3 nM PQQ increased fibroblast transcription, but the oxazole of PQQ (glycine- PQQ adduct) had no effect on mitosis." (The oxazole form of PQQ results when free PQQ undergoes a condensation reaction with an a-amino acid.) This form of PQQ has a blocked redox site, suggesting that the latter is the active locus for mitogenicity of PQQ. This evidence indicates that dietary PQQ is involved in collagen cross-linking, skin integrity, and normal immune fimction. The deficiency experiments indicate that PQQ might be a novel vitamin or an essential nutrient. A study by Kosano et al?5 found that PQQ also can block transcription; 3 nM PQQ inhib- ited the induction of tyrosinase transcription by melano- cyte-stimulating hormone (MSH), thus inhibiting melano- genesis.

PQQ as a Generator of Superoxide

PQQ can generate superoxide when given a source of elec- trons, such as NADPH, glycine, other amines, thiol com-

Nutrition Reviews, Vol. 56, No. 10 289

Page 4: Pyrroloquinoline Quinone: A Novel Vitamin?

pounds, or a ~ c o r b a t e . ~ ~ . ~ ~ Under alkaline conditions, the PQQ as a Scavenger of Superoxide orthoquinone form of PQQ oxidizes glycine, thus convert- ing PQQ to its semiquinone and hydroquinone forms. The semiquinone and hydroquinone forms of PQQ then re- duce oxygen to superoxide. This property of PQQ is the basis for the NBT-formazan assay for PQQ (Figure 2),36,37 as discussed above.

Exogenous PQQ Protects Against Oxidative Damage in Animals

In several mammalian systems in vivo, exogenous PQQ at high concentrations functions as an antioxidant. An intra- peritoneal injection of PQQ protected rats from liver dam- age caused by various hepatotoxic substances, including carbon tetrachloride, D-galactosamine, thioacetamide, and ally1 f ~ r m a t e . ~ ~ After the degree of liver damage was mea- sured, the increase in serum levels of bilirubin and glutamic- pyruvic transaminase was measured, as was the increase in liver triglycerides and lipid peroxidation. PQQ (1 1.5 mg/ kg) given within 6 hours after the administration of the toxic substance had a significant protective effect? PQQ also protected cultured hepatocyes from damage from car- bon tetra~hloride.~~ (This level of PQQ is high compared with physiologic levels.)

Rats injected intraperitoneally with PQQ also were protected against liver damage caused by ethanol load- ing.40 Metabolism of ethanol yields the damaging interme- diate acetaldehyde. Animals given ethanol without PQQ pretreatment had higher acetaldehyde levels in their blood and liver compared with PQQ-treated animals. The rate of ethanol oxidation to acetaldehyde, however, was about the same in treated and untreated animals. PQQ decreased levels of acetaldehyde by increasing the rate at which it is oxidized to acetate rather than by decreasing the rate of acetaldehyde production.'"'

PQQ also functions as an anti-inflammatory agent in rats.41 When rats received an injection of carrageenan into one of their paws, an increase in local edema and tempera- ture-indicative of an inflammatory response-resulted. When they also received PQQ (3 1.5 pg/mL) intravenously before treatment with carrageenan, the inflammatory reac- tion was decreased:'

The study by Nishigori et al." supports the hypo- thesis that PQQ protects against oxidative stress without depleting the cell's reducing equivalents. When chicks received injections of hydrocortisone, severe cataracts formed and reduced glutathione (GSH) levels were de- creased in both the lens and the liver. Chicks that received PQQ before hydrocortisone treatment exhibited much less cataract formation and had stable GSH levels in the liver and the lens. Of note is that when the chicks received PQQ alone, the amount of GSH increased in both the liver and the Supplementation with high amounts of PQQ protects animals from oxidative stress-induced damage.

In the aforementioned animal systems, PQQ has been shown to exert its protective effect by conserving reduc- ing equivalents such as GSH.42 It is classically thought that a cell uses superoxide dismutase (SOD) to remove potentially damaging superoxide by converting superox- ide to hydrogen peroxide via a dismutase reaction." How- ever, hydrogen peroxide is damaging and is removed by two reactions. It can be broken down to water and oxygen by catalase,- and it also can be scavenged by the oxida- tion of GSH to oxidized glutathione (GSSG).45 Scavenging of peroxide by the glutathione pathway depletes the cell's available reducing equivalents."

PQQ theoretically can scavenge superoxide and per- oxide without depletion of the cell's reducing equiva- l e n t ~ . ' ~ ' ~ , ~ ~ If there is excess superoxide and peroxide in the system, PQQ scavenges them by oxidizing the super- oxide anion to oxygen.lSl7 This reduced PQQ can donate its reducing equivalents to NADP' and convert it to NADPH. The NADPH can then be used to reduce GSSG to GSH. Instead of taking reducing equivalents from NADPH, as PQQ does when it generates su~e rox ide ,~~ PQQ donates reducing equivalents. The reactions occur according to the following two equations:

(1)

Thus, scavenging of superoxide with PQQ is less expen- sive to the reducing economy of the cell than the classic scavenging system. 15-17

PQQ(2H) + NADP + NADPH +H+ + PQQ, NADPHTH++ GSSG+2GSH+NADI?. (2)

PQQ in the Brain

PQQ is of particular importance in the brain. In vitro ex- periments demonstrated its ability to inhibit the action of porcine brain 4-aminobutyrate aminotransferase by oxi- dizing its dithiol gr0up.4~PQQ also has been shown to inhibit glutamate decarboxylase in the porcine It has been proposed that native PQQ in the brain would inhibit these enzymes in viv0.4~3~~ Because glutamate de- carboxylase removes the carboxyl group from glutamate and yields y-aminobutyric acid (GABA), one might imag- ine that its inhibition by high levels of PQQ in the brain might result in increased glutamate levels. The increased glutamate levels would overstimulate NMDA receptors, causing production of the free radicals nitric oxide and superoxide, which then, by themselves or as a peroxynitrite anion, cause oxidative damage that leads to cell

Paradoxically, PQQ seems to protect astrocyte-rich cortical neuron cultures against NMDA receptor-medi- ated glutamate ex~ i to tox ic i ty .~~~~~ Glutamate toxicity was significantly diminished when neurons were pretreated with PQQ (1 6.5 pg/mL).48*49 The ability of PQQ to protect against excitotoxicity was inhibited by an agent that alky- lates thiol groups (N-ethyl maleimide). It was inferred from

290 Nutrition Reviews, Vol. 56, No. 10

Page 5: Pyrroloquinoline Quinone: A Novel Vitamin?

this that PQQ exerted its effects on the dithiol redox modu- latory group on the NMDA re~eptor .4~*~~ In fact, PQQ in vitro has been shown to oxidize thiol groups (see ab0ve).4~A~ The alkylating agent may block other sites of action for PQQ or it may interact with PQQ itself and in this way inhibit its action. However, in light of the fact that PQQ increases glutamate levels, it is puzzling that PQQ would protect against rather than exacerbate glutamate toxicity.

Intraperitoneal injection of an extremely high dose of PQQ (1 0 mg/kg) also appears to protect against hypoxic/ ischemic injury and seizure activity in the neonatal rat stroke model. The damage from stroke may be caused by NMDA receptor-mediated excitotoxicity.sO In the whole animal, the protective effect exerted by PQQ may be through its ability to scavenge the free radicals produced by NMDA receptor-mediated excitotoxicity rather than by its ability to oxidize the redox modulatory region on the NMDA receptor itself.

Because PQQ scavenges superoxide in high-super- oxide conditions and generates superoxide in low-saper- oxide conditions, there is a question of the appropriate redox form of PQQ entering a stroked brain and specifi- cally affecting the infarcted area.1sJ8J9,37 Perhaps the PQQ- mediated diminution of the infarcted area in stroke brains is due to PQQ decreasing the damage to the infarcted tissue while causing damage to the surrounding nonin- farcted tissues, thus smearing the border between the in- farction and healthy tissue and giving the false appear- ance of amelioration.

PQQ has been shown to stimulate the synthesis of nerve growth factor (NGF) in mouse astroglial cell^.^' Free PQQ increased the production of NGF in vitro but not in vivo. The oxazole of PQQ increased the total brain con- tent ofNGF in rats, whereas fiee PQQ did not.5' The oxazole derivatization allowed PQQ to cross the blood-brain bar- rier to exert its effects on NGF synthesis. PQQ in its free form cannot cross the blood-brain barrier and has no ef- fect, perhaps for that reas~n.~ '*~*

The observation that free PQQ cannot cross the blood-brain barrier puts the animal stroke model into ques- tion. One might wonder how PQQ can exert its protective effects in the stroke model when it cannot reach the brain. The rat pups used for the stroke model may have been young enough to have an incomplete blood-brain barrier.

Implications

In summary, PQQ is a dietary component that is absorbed by animals. This component is normally excreted in high concentrations in colostrum and milk, which might indi- cate that it is needed by the neonate. When animals are deprived of PQQ, there is reduced health and reproduc- tive ability in adults and loss of viability in neonates. When PQQ is administered in large amounts, it provides signifi-

cant protection against oxidative stress. Current research provides strong evidence that PQQ may be considered a novel vitamin required by adult animals for health and by neonates for survival.

Acknowledgment. This work was supported by grants from the National Institutes of Health and was partially funded by the National Dairy Promotion and Research Board and administered in cooperation with the National Dairy Council.

Dedication. This review is dedicated to the memory of Dr. Paul M. Gallop, who saw earlier versions of this paper and was the first to discover PQQ in animal sys- tems. He was a careful yet bold scientist who will be re- membered as one of the great pioneers. Paul pursued knowledge for its own sake and collaborated to advance answers to a question rather than to advance himself. He was generous with his time and ideas and he was a great mentor and friend.

1.

2.

3.

4.

5.

6.

7.

8.

9.

10.

11.

Salisbury SA, Forrest HS, Cruse WBT. A novel coen- zyme from bacterial primary alcohol dehydrogena- ses. Nature 1979;280:843-4 Corey EJ, Tramantano A. Total synthesis of the quinonoid alcohol dehydrogenase coenzyme of methylotropic bacteria. J Am Chem SOC 1981303:

Duine JA, Jongegan JA. Quinoproteins: enzymes with pyrroloquinoline quinone as a cofactor. Annu Rev Biochem 1989;58:403-26 Groen BW, Van der Meer RA, Duine JA. Evidence for PQQ as cofactor in 3,4-dihydroxyphenylalanine (dopa) decarboxylase of pig kidney. FEES Lett

Moog RS, McGuirl MA, Cote CE, Dooley DM. Evi- dence for methoxatin (pyrroloquinoline quinone) as the cofactor of bovine plasma amine oxidase from resonance spectroscopy. Proc Natl Acad Sci U S A

Van der Meer RA, Duine JA. Pyrroloquinoline quinone (PQQ) is the organic cofactor in soybean lipoxy- genase-1 . FEBS Lett 1988;235:194-200 Van der Meer RA, Jongejan JA, Duine JA. Dopamine p-hydroxylase from bovine adrenal medulla contains covalently-bound pyrroloquinoline quinone. FEES Lett 1988;231:303-7 Van der Meer RA, Van Wassenaar PD, Van Browershaven JH, Duine JA. Primary structure of a pyrroloquinoline quinone (PQQ)-containing peptide isolated from porcine kidney diamine oxidase. Biochem Biophys Res Commun 1989;159:7826-33 Tinker D, Rucker RB. Role of selected nutrients in synthesis, accumulation, and chemical modification of connective tissue proteins. Physiol Rev 1985;65:

Shah M, Bergethon F1 Boak A, et at. Oxidation of peptydyl lysine by copper complexes and other quin- ones: a model for oxidative pathochemistry. Biochem Biophys 1992;1159:311-8 Kagan HM. Characterization and regulation of lysyl oxidase. In: Mecham RE ed. Biology of the extracel- lular matrix, vol 1. Orlando, FL: Academic Press,

5599-5600

1988;237:98-102

1986;83:8435-9

607-57

Nutrition Reviews, Vol. 56, No. 10 29 1

Page 6: Pyrroloquinoline Quinone: A Novel Vitamin?

12.

13.

14.

15.

16.

17.

18.

19.

20.

21.

22.

23.

24.

25.

26.

27.

28.

29.

292

1986;321-98 Klinman JI? Dooley DM, Duine JA, et al. Status of the cofactor identity in copper oxidative enzymes. FEBS Lett 1991;282:1-4 Harris ED. The pyrroloquinoline quinone (PQQ) co- enzymes: a case of mistaken identity. Nutr Rev

Gallop PM, Paz MA, Fluckiger R. The biological sig- nificance of quinoid compounds in, on, and out of proteins. Chemtracts Biochem Mol Biol 1990;1:357- 74 Fluckiger R, Paz MA, Mah J, et al. Characterization of the glycine-dependent redox-cycling activity in ani- mal fluids and tissues using specific inhibitors and activators: evidence for presence of PQQ. Biochem Biophys Res Commun 1993;196:61-8 Paz MA, Fluckiger R, Gallop PM. The biomedical sig- nificance of PQQ. In: Davidson VL, ed. Principles and applications of quinoproteins. New York: Marcel Dekker, 1992;357-74 Gallop PM, Paz MA, Fluckiger R, Henson E. Is the antioxidant, anti-inflammatory, putative new vitamin, PQQ, involved with nitric oxide in bone metabolism? Connect Tissue Res 1993;29:153-61 Bishop A, Paz M, Gallop F: Karnovsky ML. Maoxatin (PQQ) in guinea pig neutrophils. Free Radic Biol Med

Bishop A, Paz M, Gallop R Karnovsky ML. Inhibition of redox cycling of methoxatin (PQQ) and of superox- ide release by phagocytic white cells. Free Radic Biol Med 1995;18:617-20 Paz MA, Martin I? Fluckiger R, et al. The catalysis of redox cycling by pyrroloquinoline quinone (PQQ), PQQ derivatives, and isomers and the specificity of inhibitors. Anal Biochem 1996;238:145-9 Kumazawa T, Sat0 K, Sen0 H, et al. Levels of pyrroloquinoline quinone in various foods. Biochem J 1995;307:331-3 KumazawaT, Sen0 H, Suzuki 0. Failure to verify high levels of pyrroloquinoline quinone in eggs and skim milk. Biochem Biophys Res Commun 1993;193(1):1- 5 Gatley J, Sherratt SA. The effect of diphenylene- iodonium on mitochondria1 reactions. Biochem J

Gallop PM, Paz MA, Fluckiger R, et al. Highly effec- tive PQQ inhibition by alkynyl and aryl mono- and diiodonium salts. J Am Chem SOC 1993;115:11702- 4 Xu F, Mack CR Quandt KS, et al. Pyrroloquinoline quinone acts with flavin reductase to reduce ferrylmyoglobin in vitro and protects isolated heart from re-oxygenation injury. Biochem Biophys Res Commun 1993;193(1):434-9 Babior BM, Kipnes RS, Curnutte JT. Biological d e fense mechanisms: the production by leukocytes of superoxide, a potential bactericidal agent. J Clin In- vest 1973;52:741 Badwey JA, Karnovsky ML. Production of superoxide and hydrogen peroxide by an NADH-oxidase in guinea pig polymorphonuclear leukocytes. J Biol Chem 1979;254:11530-7 Cross AR. Inhibitors of the leukocyte superoxide gen- erating oxidase. Free Radic Biol Med 1990;8:71-93 Doussiere J, Vignais PV. Diphenylene iodonium as

1992;50:263-74

1994;17:311-20

1976;158:307-15

30.

31.

32.

33.

34.

35.

36.

37.

38.

39.

40.

41.

42.

43.

44.

45.

46.

an inhibitor of the NADPH oxidase complex of bovine neutrophils. Eur J Biochem 1992;208:61-71 Steinberg FM, Smidt C, Kilgore J, et al. PQQ: effect on growth, reproduction, immune function, and extracel- Mar matrix maturation in mice. In: Davidson VL, ed. Principles and applications of quinoproteins. New York: Marcel Dekker, 1993;367-80 Smidt CR, Steinberg FM, Rucker RB. Physiologic im- portance of pyrroloquinoline quinone. Proc SOC Exp Biol Med 1991 ;197:19-26 Killgore J, Smidt C, Duich L, et al. Nutritional impor- tance of pyrroloquinoline quinone. Science

Schillings ED, Strong FM. Isolation, structure, and synthesis of a lathyrus factor from L. odoratus. J Am Chem SOC 1954;76:28-48 Naito V, Kumazawa T, Kin0 I, Suzuki 0. Effects of pyrroloquinoline quinone (PQQ) and PQQ-oxazole on DNA-synthesis of cultured human fibroblasts. Life Sci 1993;52(24): 1909-1 5 Kosano H, Setogawa T, Kobayashi K, Nishigori H. Pyrroloquinoline quinone (PQQ) inhibits the expres- sion of tyrosinase mRNA by a-melanocyte stimulat- ing hormone in murine B16 melanoma cells. Life Sci

Paz MA, Gallop PM, Torrelio BM, Fluckiger R. The amplified detection of free and bound methoxatin (PQQ) with nitroblue tetrazolium redox reactions: in- sights into the PQQ locus. Biochem Biophys Res Commun 1988;154:1330-7 Sugioka K, Nakano M, Naito L, et al. Properties of a coenzyme, pyrroloquinoline quinone: generation of an active oxygen species during a reduction-oxida- tion cycle in the presence of NAD(P)H and 0,. Biochem Biophys 1988;964:175-82 Watanabe A, Hobara N, Tsuji T. Protective effect of pyrroloquinoline quinone against experimental liver injury in rats. Current Therap Res 1988;44:896-901 Tsuchida T, Yasuyama T, Higuchi K, et al. The protec- tive effect of pyrroloquinoline quinone and its deriva- tives against carbon tetrachloride-induced liver in- jury of rats. J Gastroenterol Hepatol 1993;8:342-7 Hobara N, Watanabe A, Kobayshi M, Tsuji T. Quinone derivatives lower blood and liver acetaldehyde but not ethanol concentrations following ethanol loading to rats. Pharmacology 1989;37:264-7 Hamagishi V, Murata S, Ramei H, et al. New biologi- cal properties of pyrroloquinoline quinone and its re- lated compounds: inhibition of chemiluminescence, lipid peroxidation, and rat paw edema. J Pharmacol Exp Therap 1990;255:980-5 Nishigori H, Yasanaga M, Mizumura M, et al. Preven- tative effect of pyrroloquinoline quinone on formation of cataract and decline of lenticular and hepatic glu- tathione of developing chick embryo after glucocorti- coid treatment. Life Sci 1989;44:5938 McCord JM, Fridovich I. Superoxide dismutase. J Biol Chem 1969;244:6049-55 Yost FJ Jr, Fridovich 1. Superoxide radicals and phago- cytosis. Arch Biochem Biophys 1974;161:395-401 Lopez-Barea J, Lee CY Mouse liver glutathione-re ductase purification, kinetics, and regulation. Eur J Biochem 1979;98:487-99 Park J, Churchich JE. Interaction of thioredoxin with oxidized aminobutyrate aminotransferase: evidence

1989;245:850-2

1995;56:1707-13

Nutrition Reviews, Vol. 56, No. 10

Page 7: Pyrroloquinoline Quinone: A Novel Vitamin?

for the formation of a covalent intermediate. FEBS Lett 1992;310:1-4 Choi SY Khemlani LS, Churchich JE. Brain glutamate decarboxylase and pyrroloquinoline quinone. Biofactors 1992;3(3):191-6 Aizenman E, Jensen FE, Gallop PM, et al. Further evidence that pyrroloquinoline quinone interacts with the N-methyl-D-aspartate receptor redox site in rat cortical neurons in vitro. Neurosci Lett 1994;168:189- 92 Aizenman E, Hartnett KA, Zhong C, et al. Interaction of the putative essential nutrient pyrroloquinoline quinone with the N-methyl-D-aspartate receptor re-

47.

48.

49.

dox modulatory site. J Neurosci 19923 22362-9 Jensen FR, Gardner GJ, Williams AR et al. The puta- tive essential nutrient pyrroloquinoline quinone is neuroprotective in a rodent model of hypoxichschemic brain injury. Neuroscience 1994;62:399-406 Murase K, Hattori A, Kohno M, Hayashi K. Stimula- tion of nerve growth factor synthesislsecretion in mouse astroglial cells by coenzymes. Biochem Mol Biol Int 1993;30:615-21

52. Yamaguchi K, Sasano A, Urakami T, et al. Stimulation of nerve growth factor production by pyrroloquinoline quinone and its derivatives in vitro and in vivo. Biosci Biotech Biochem 1993;57:1231-3

50.

51.

Nutrition Reviews, Vol. 56, No. 10 293